PTC Therapeutics Inc (PTCT)
42.94
+0.05
(+0.12%)
USD |
NASDAQ |
Nov 22, 10:34
PTC Therapeutics Profit Margin (Quarterly): -54.20% for Sept. 30, 2024
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | -54.20% |
| June 30, 2024 | -53.12% |
| March 31, 2024 | -43.58% |
| December 31, 2023 | -50.74% |
| September 30, 2023 | -67.64% |
| June 30, 2023 | -93.02% |
| March 31, 2023 | -63.05% |
| December 31, 2022 | -102.1% |
| September 30, 2022 | -50.35% |
| June 30, 2022 | -91.88% |
| March 31, 2022 | -85.20% |
| December 31, 2021 | -86.71% |
| September 30, 2021 | -96.31% |
| June 30, 2021 | -101.5% |
| March 31, 2021 | -109.1% |
| December 31, 2020 | -62.55% |
| September 30, 2020 | -58.86% |
| June 30, 2020 | -241.1% |
| March 31, 2020 | -165.1% |
| December 31, 2019 | -80.53% |
| September 30, 2019 | -84.01% |
| June 30, 2019 | -48.86% |
| March 31, 2019 | -134.6% |
| December 31, 2018 | -55.98% |
| September 30, 2018 | -95.11% |
| Date | Value |
|---|---|
| June 30, 2018 | -13.85% |
| March 31, 2018 | -34.36% |
| December 31, 2017 | 1.63% |
| September 30, 2017 | -80.61% |
| June 30, 2017 | -36.44% |
| March 31, 2017 | -109.5% |
| December 31, 2016 | -106.4% |
| September 30, 2016 | -153.0% |
| June 30, 2016 | -248.9% |
| March 31, 2016 | -218.2% |
| December 31, 2015 | -400.1% |
| September 30, 2015 | -442.1% |
| June 30, 2015 | -566.3% |
| March 31, 2015 | -506.7% |
| December 31, 2014 | -196.4% |
| September 30, 2014 | -3.42K% |
| June 30, 2014 | -1.77K% |
| March 31, 2014 | -154.1% |
| December 31, 2013 | -245.0% |
| September 30, 2013 | -28.57% |
| June 30, 2013 | -248.6% |
| March 31, 2013 | -241.8% |
| December 31, 2012 | -106.0% |
| September 30, 2012 | -120.8% |
| June 30, 2012 | -100.1% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-241.1%
Minimum
Jun 2020
-43.58%
Maximum
Mar 2024
-87.83%
Average
-82.87%
Median
Profit Margin (Quarterly) Benchmarks
| ClearPoint Neuro Inc | -61.24% |
| Pfizer Inc | 25.22% |
| Vertex Pharmaceuticals Inc | 37.71% |
| BridgeBio Pharma Inc | -5.93K% |
| Cassava Sciences Inc | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Assets | -26.03% |
| Gross Profit Margin (Quarterly) | 94.49% |
| Operating Margin (Quarterly) | -26.41% |
| Return on Net Operating Assets | -55.71% |